Biodesy Receives $10,000,000 Series B Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=88f27189-72e6-476a-a2ce-ca10cadfddfd - Date
1/25/2016 - Company Name
Biodesy - Mailing Address
384 Oyster Point Blvd. South San Francisco, CA 94080 USA - Company Description
Biodesy has developed a unique and highly sensitive means of detecting conformational change in proteins and other biological molecules. Our technology, based on a phenomenon called ‘second-harmonic generation’ (SHG), can monitor structural change at any site within a protein, in real time. - Website
http://www.biodesy.com - Transaction Type
Venture Equity - Transaction Amount
$10,000,000 - Transaction Round
Series B - Proceeds Purposes
Proceeds from the financing will be used to expand and accelerate commercialization of the Biodesy Delta System, a new, real-time, high-throughput platform that enables researchers to measure conformational change in their own laboratories. - M&A Terms
- Venture Investor
5AM Ventures - Venture Investor
Pfizer Venture Investments - Venture Investor
Roche Venture Fund
